Filtered By:
Drug: Prozac
Management: National Institutes of Health (NIH)
This page shows you your search results in order of date.
Order by Relevance | Date
Total 14 results found since Jan 2013.
Measuring Ambulation, Motor, and Behavioral Outcomes with Poststroke Fluoxetine in Tanzania: The Phase II MAMBO Trial
Am J Trop Med Hyg. 2021 Dec 6:tpmd210653. doi: 10.4269/ajtmh.21-0653. Online ahead of print.ABSTRACTWe test the safety of fluoxetine postischemic stroke in sub-Saharan Africa. Adults with acute ischemic stroke, seen <14 days since new-onset motor deficits, were enrolled from November 2019 to October 2020 in a single-arm, open-label phase II trial of daily fluoxetine 20 mg for 90 days at Muhimbili National Hospital, Dar es Salaam, Tanzania. The primary outcome was safety with secondary outcomes of medication adherence and tolerability. About 34 patients were enrolled (11 were female; mean age 52.2 years, 65% < 60 year...
Source: Am J Trop Med Hyg - December 6, 2021 Category: Infectious Diseases Authors: Farrah Mateen Emmanuel Massawe Notburga Mworia Seif Ismail Dylan Rice Andre Vogel Boniface Kapina Novath Mukyanuzi Deus Buma Jef Gluckstein Michael Wasserman Susan Fasoli Faraja Chiwanga Kigocha Okeng'o Source Type: research
Why Scientists Need to Embrace Crowdfunding
From the junior physician attempting to start a pilot study to the seasoned researcher in the final years of an academic grant, the harsh reality of medical research funding constantly looms. Young researchers have faced the worst funding in half a century. The competition for public research grants has intensified to the point where less than 15% of proposals obtain funding. The $1.55 billion budget cut to the National Institute of Health (NIH) in 2013 alone resulted in an estimated 640 fewer research studies receiving funding. Researchers are now encouraged to prepare for grant applications years in advance and to expect...
Source: Science - The Huffington Post - November 19, 2015 Category: Science Source Type: news
Is Ketamine Right for You? Off-Label Prescriptions for Depression Pick Up in Small Clinics, Part 2
Dennis Hartman, a 47-year-old former business executive for an Illinois gaming company, described the diagnosis he had been given as “major depression disorder with severity of the extreme, social phobia and generalized anxiety disorder,” something he had lived with for more than 30 years. He had tried Prozac-like drugs, an earlier generation of antidepressants, tranquilizers, mood stabilizers, supplements, meditation and psychotherapy. Nothing helped.Last year he set a date and made a plan for how he would take his own life. He had given himself some time to get his affairs in order to cause as little distress...
Source: Scientific American - Official RSS Feed - September 12, 2013 Category: Science Tags: Health,More Science,Mind & Brain Source Type: research
